Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Drug-Eluting Bioabsorbable Stents Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Drug-Eluting Bioabsorbable Stents Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Serolimus and Paclitaxel Drug-Eluting Stents
      • 1.3.3 Sirolimus Drug Eluting Stents
    • 1.4 Market Segment by Application
      • 1.4.1 Global Drug-Eluting Bioabsorbable Stents Market Share by Application (2019-2025)
      • 1.4.2 Coronary Artery Diseases
      • 1.4.3 Peripheral Artery Diseases
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Drug-Eluting Bioabsorbable Stents Market Size
      • 2.1.1 Global Drug-Eluting Bioabsorbable Stents Revenue 2014-2025
      • 2.1.2 Global Drug-Eluting Bioabsorbable Stents Sales 2014-2025
    • 2.2 Drug-Eluting Bioabsorbable Stents Growth Rate by Regions
      • 2.2.1 Global Drug-Eluting Bioabsorbable Stents Sales by Regions 2014-2019
      • 2.2.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Drug-Eluting Bioabsorbable Stents Sales by Manufacturers
      • 3.1.1 Drug-Eluting Bioabsorbable Stents Sales by Manufacturers 2014-2019
      • 3.1.2 Drug-Eluting Bioabsorbable Stents Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Drug-Eluting Bioabsorbable Stents Revenue by Manufacturers (2014-2019)
      • 3.2.2 Drug-Eluting Bioabsorbable Stents Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Drug-Eluting Bioabsorbable Stents Market Concentration Ratio (CR5 and HHI)
    • 3.3 Drug-Eluting Bioabsorbable Stents Price by Manufacturers
    • 3.4 Key Manufacturers Drug-Eluting Bioabsorbable Stents Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Drug-Eluting Bioabsorbable Stents Market
    • 3.6 Key Manufacturers Drug-Eluting Bioabsorbable Stents Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Serolimus and Paclitaxel Drug-Eluting Stents Sales and Revenue (2014-2019)
      • 4.1.2 Sirolimus Drug Eluting Stents Sales and Revenue (2014-2019)
    • 4.2 Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type
    • 4.3 Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Type
    • 4.4 Drug-Eluting Bioabsorbable Stents Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Drug-Eluting Bioabsorbable Stents Sales by Application

    6 United States

    • 6.1 United States Drug-Eluting Bioabsorbable Stents Breakdown Data by Company
    • 6.2 United States Drug-Eluting Bioabsorbable Stents Breakdown Data by Type
    • 6.3 United States Drug-Eluting Bioabsorbable Stents Breakdown Data by Application

    7 European Union

    • 7.1 European Union Drug-Eluting Bioabsorbable Stents Breakdown Data by Company
    • 7.2 European Union Drug-Eluting Bioabsorbable Stents Breakdown Data by Type
    • 7.3 European Union Drug-Eluting Bioabsorbable Stents Breakdown Data by Application

    8 China

    • 8.1 China Drug-Eluting Bioabsorbable Stents Breakdown Data by Company
    • 8.2 China Drug-Eluting Bioabsorbable Stents Breakdown Data by Type
    • 8.3 China Drug-Eluting Bioabsorbable Stents Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Drug-Eluting Bioabsorbable Stents Breakdown Data by Company
    • 9.2 Rest of World Drug-Eluting Bioabsorbable Stents Breakdown Data by Type
    • 9.3 Rest of World Drug-Eluting Bioabsorbable Stents Breakdown Data by Application
    • 9.4 Rest of World Drug-Eluting Bioabsorbable Stents Breakdown Data by Countries
      • 9.4.1 Rest of World Drug-Eluting Bioabsorbable Stents Sales by Countries
      • 9.4.2 Rest of World Drug-Eluting Bioabsorbable Stents Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Medtronic
      • 10.1.1 Medtronic Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Drug-Eluting Bioabsorbable Stents
      • 10.1.4 Drug-Eluting Bioabsorbable Stents Product Introduction
      • 10.1.5 Medtronic Recent Development
    • 10.2 B.Braun Melsungen
      • 10.2.1 B.Braun Melsungen Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Drug-Eluting Bioabsorbable Stents
      • 10.2.4 Drug-Eluting Bioabsorbable Stents Product Introduction
      • 10.2.5 B.Braun Melsungen Recent Development
    • 10.3 Abbott Laboratories
      • 10.3.1 Abbott Laboratories Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Drug-Eluting Bioabsorbable Stents
      • 10.3.4 Drug-Eluting Bioabsorbable Stents Product Introduction
      • 10.3.5 Abbott Laboratories Recent Development
    • 10.4 Boston Scientific Corporation
      • 10.4.1 Boston Scientific Corporation Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Drug-Eluting Bioabsorbable Stents
      • 10.4.4 Drug-Eluting Bioabsorbable Stents Product Introduction
      • 10.4.5 Boston Scientific Corporation Recent Development
    • 10.5 Biosensors International
      • 10.5.1 Biosensors International Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Drug-Eluting Bioabsorbable Stents
      • 10.5.4 Drug-Eluting Bioabsorbable Stents Product Introduction
      • 10.5.5 Biosensors International Recent Development
    • 10.6 Terumo Corporation.
      • 10.6.1 Terumo Corporation. Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Drug-Eluting Bioabsorbable Stents
      • 10.6.4 Drug-Eluting Bioabsorbable Stents Product Introduction
      • 10.6.5 Terumo Corporation. Recent Development
    • 10.7 MicroPort Scientific Corporation
      • 10.7.1 MicroPort Scientific Corporation Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Drug-Eluting Bioabsorbable Stents
      • 10.7.4 Drug-Eluting Bioabsorbable Stents Product Introduction
      • 10.7.5 MicroPort Scientific Corporation Recent Development
    • 10.8 Alvimedica
      • 10.8.1 Alvimedica Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Drug-Eluting Bioabsorbable Stents
      • 10.8.4 Drug-Eluting Bioabsorbable Stents Product Introduction
      • 10.8.5 Alvimedica Recent Development
    • 10.9 Biotronik
      • 10.9.1 Biotronik Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Drug-Eluting Bioabsorbable Stents
      • 10.9.4 Drug-Eluting Bioabsorbable Stents Product Introduction
      • 10.9.5 Biotronik Recent Development
    • 10.10 Elixir Medical Corporation
      • 10.10.1 Elixir Medical Corporation Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Drug-Eluting Bioabsorbable Stents
      • 10.10.4 Drug-Eluting Bioabsorbable Stents Product Introduction
      • 10.10.5 Elixir Medical Corporation Recent Development
    • 10.11 Innovative Health Technologies

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Drug-Eluting Bioabsorbable Stents Sales Channels
      • 11.2.2 Drug-Eluting Bioabsorbable Stents Distributors
    • 11.3 Drug-Eluting Bioabsorbable Stents Customers

    12 Market Forecast

    • 12.1 Global Drug-Eluting Bioabsorbable Stents Sales and Revenue Forecast 2019-2025
    • 12.2 Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Type
    • 12.3 Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Application
    • 12.4 Drug-Eluting Bioabsorbable Stents Forecast by Regions
      • 12.4.1 Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Drug-Eluting Bioabsorbable Stents is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Drug-Eluting Bioabsorbable Stents.

      This report studies the global market size of Drug-Eluting Bioabsorbable Stents, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Drug-Eluting Bioabsorbable Stents sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Medtronic
      B.Braun Melsungen
      Abbott Laboratories
      Boston Scientific Corporation
      Biosensors International
      Terumo Corporation.
      MicroPort Scientific Corporation
      Alvimedica
      Biotronik
      Elixir Medical Corporation
      Innovative Health Technologies

      Market Segment by Product Type
      Serolimus and Paclitaxel Drug-Eluting Stents
      Sirolimus Drug Eluting Stents

      Market Segment by Application
      Coronary Artery Diseases
      Peripheral Artery Diseases

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Drug-Eluting Bioabsorbable Stents status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Drug-Eluting Bioabsorbable Stents manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Drug-Eluting Bioabsorbable Stents are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now